Delivery Order SPE2DB25D3005-SPE2DB25FQCHL
Award Date
2/6/25
Potential Completion Date
2/7/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $1,625.81 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets (30 count) to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,586.96 and a completion date of January 30, 2025. The contract was awarded on January 29, 2025 and does not have a...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA), a major defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a large pharmaceutical distributor, on December 18, 2024, with a ceiling value of $2,322.07 and a completion date of December 19, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of 4,567,171,124 units of ondansetron ODT 4 mg tablets in packages of 30 to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,811.42, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm-fixed-price delivery order with a completion date of February 6, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award is for the delivery of 4,566,371,764 units of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $2,152.42 firm fixed-price delivery order was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of November 8, 2024 and was awarded on November 7, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company that is a subsidiary of the parent company Cencora, Inc. The total ceiling value of the contract is $1,327.99, with a period of performance through April 25, 2023. This is a Firm Fixed Price Delivery Order contract, without any set-aside...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets in packages of 30 to the Defense Logistics Agency (DLA). The contract, valued at $11,710.83, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on May 22, 2024. The contract is a firm fixed-price Delivery Order with a completion date of May 23, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the provision of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $78,266.61. It does not have a Set-Aside designation, indicating open competition. The contract has an Ultimate Completion Date of December 18, 2024 and was awarded on December...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets in quantities of 30 tablets per bottle. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed price of $1,751.14 and a completion date of November 13, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablet supplies to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor for this $18,477.96 Firm Fixed Price Delivery Order is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract has an ultimate completion date of October 24, 2023 and was awarded on October 23, 2023. The contract is not designated with any set-aside...